AI Assistant
Blog
Pricing
Log In
Sign Up
Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.